Purchase Order HHSF223201610174P
Award Date 4/27/16
Potential Completion Date 5/1/18
Potential Value $316K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $97,136.00, was issued by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Corporation, for upgrades and additional imaging equipment for an existing Bruker BioSpec 4.7 T 40 cm bore system with an Avance III console magnetic resonance imaging (MRI) system. The contract does not have a set-aside designation, indicating it was competitively awarded. Bruker Biospin Corp has extensive experience providing specialized...
- This firm-fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a manufacturer of scientific instruments and equipment, for the delivery of a Cryo Probe for Nuclear Magnetic Resonance (NMR) analysis. The contract has a potential value of $187,725.00 and a completion date of December 31, 2020. Bruker Biospin Corp is a subsidiary of Bruker Corporation, which provides specialized equipment, maintenance, and support...
- The Department of Health and Human Services Food and Drug Administration awarded a $879,190.00 firm fixed price purchase order to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, to upgrade the agency's 500 and 700 MHz nuclear magnetic resonance (NMR) spectrometers. The contract, which does not have a set-aside designation, will provide new equipment, including a new cryoprobe, backup room temperature probe, and automated sample changers, to improve the sensitivity and...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, in the amount of $238,161.00. The contract is for the delivery of a cryogenically-cooled 13C direct detect probe and 3 years of preventative maintenance for an existing Bruker nuclear magnetic resonance (NMR) spectrometry system. There was no set-aside designation for this award. The original...
- This federal contract award to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, is for a maintenance agreement on a specialized scientific instrumentation package. The award, valued at $180,527.72, covers a LABSCAPE complete system including a nuclear magnetic resonance (NMR) console, cryoplatform, and multiple cryogenic probes. The contract provides for two helium fill-ups per year on this equipment through June 16, 2025. The contract was awarded by the Food and Drug Administration...
- The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp, a manufacturer of scientific instruments, a $398,050.00 firm-fixed-price purchase order contract to provide an NMR 400 console upgrade and deuterium probe. The contract was not set aside. Bruker Biospin Corp is a subsidiary of Bruker Corporation, which provides specialized equipment, maintenance, and support services to various U.S. federal government agencies. This award supports the FDA's...
- This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, for the provision of nuclear magnetic resonance (NMR) equipment and services. The contract has a ceiling value of $1,334,738.00 and a period of performance ending on July 31, 2017. The contract was awarded on a full and open competition basis, with no set-aside designation. Bruker Biospin Corp is a manufacturer of advanced...
- The U.S. Food and Drug Administration awarded a $677,948.68 firm fixed price purchase order to Bruker Biospin Corp for a 400 MHz Nuclear Magnetic Resonance (NMR) spectrometer on September 29, 2021. The contract, which was completed by September 28, 2022, fulfills the FDA's Center for Drug Evaluation and Research requirement for high-resolution analytical equipment to characterize pharmaceutical ingredients, drug products, and excipients for stability and quality assessment in both liquid and...
- The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, for the procurement of a 400MHz NMR spectrometer food screening system, under solicitation FDA-RFQ-CFSAN-2024-121654. The total ceiling value of the contract is $359,990.00, with a completion date of July 4, 2025. This award is not associated with a set-aside program. Bruker Biospin Corp is a manufacturer of scientific instruments and has a...
- This federal contract award is for an LAB INSTRUMENT CONTROLLER UPGRADE worth $6,500.00 issued by the Food and Drug Administration (FDA) to the prime contractor Bruker Biospin Corp. The contract is a Firm Fixed Price Purchase Order with a completion date of November 2, 2013. The award does not have a set-aside designation. Bruker Biospin Corp is a wholly owned subsidiary of the Bruker Corporation, a global scientific instrumentation company that provides a wide range of analytical and diagnostic...